Hormonal abnormalities in azoospermic men in Kano, Northern Nigeria



Similar documents
How to Find Out What s Wrong A BASIC GUIDE TO MALE. A doctor s guide for patients developed by the American Urological Association, Inc.

EVALUATION OF FSH, LH AND TESTOSTERONE LEVELS IN DIFFERENT SUBGROUPS OF INFERTILE MALES

Male Hypogonadism. Hypogonadism is characterised by impaired testicular function, which may affect spermatogenesis and/or testosterone synthesis.

Clinical Policy Committee

BIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE

The ABC s and T s of Male Infertility

The relevant NICE Clinical Guidance 156, Fertility can be accessed here:

Male Health Issues. Survivorship Clinic

GUIDELINES FOR THE INVESTIGATION AND TREATMENT OF MALE INFERTILITY

Tower Hamlets CCG Fertility policy

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

Continuity Clinic Educational Didactic. December 8 th December 12 th

Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.

Topic: Male Factor Infertility

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

Artificial insemination

Endocrinology of the Female Reproductive Axis

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

Anatomy and Physiology of Human Reproduction. Module 10a

Testosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division

Male Infertility. Penis. Epididymis

Drug Therapy Guidelines: Injectable Fertility Medications

Infertility Causes, Prevention and Programmatic strategies

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY

Reproductive Technology. Chapter 21

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

Varicocele: To Fix or Not to Fix? That is the Question. Edmund S. Sabanegh, MD

London Fertility Centre Price List

Assisted Reproductive Technologies at IGO

Reproduction Multiple Choice questions

Assisted Reproductive Technologies

Artificial insemination with donor sperm

Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006

2. What muscle pulls the testis down into the scrotum during development?

INFERTILITY/POLYCYSTIC OVARIAN SYNDROME. Ovulatory Dysfunction: Polycystic ovarian syndrome (PCOS)

Assisted Conception Policy. February Dr. Liz Saunders Cyril Haessig

Male Infertility and Assisted Reproductive Technology: Lessons from the IVF

Role of Optimizing Testosterone Before Microdissection Testicular Sperm Extraction in Men with Nonobstructive Azoospermia

Clinical Reference Group Quality & Safety Committee Governing Body. Policy Screened

Causes for unintentional childlessness

CENTER FOR SPECIAL MINIMALLY INVASIVE SURGERY Camran Nezhat, MD and Associates 900 Welch Road, Suite 403 Palo Alto, CA (650)

EFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY

HUMAN SEMEN QUALITY IN THE NEW MILLENIUM: A MATTER OF CONCERN?

The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells

ANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM

Smoking and Age of Menopause. Women who smoke experience menopause an average of 2 years earlier than women who do not smoke.

Male New Patient Package

AN INFORMATION LEAFLET

Page The production of monoploid cells by spermatogenesis occurs in (1) zygotes (3) ovaries (2) testes (4) meristems

Focus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS

HEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)

Cell Phone Usage and Semen Quality, Hospital Based Study M El-Helaly 1*, M Mansour 2

Unit 3 REPRODUCTIVE SYSTEMS AND THE MENSTRUAL CYCLE

In - Vitro Fertilization Handbook

VASECTOMY. Information Leaflet. Your Health. Our Priority.

Preparation for your vasectomy

Reduced Ovarian Reserve Is there any hope for a bad egg?

Testosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E

Endocrine Responses to Resistance Exercise

Understanding Fertility

University Hospitals Coventry and Warwickshire NHS Trust. Centre for Reproductive Medicine. We Care. We Achieve. We Innovate.

Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES

Fertility care for women diagnosed with cancer

Trends in Male Reproductive Health

Alcohol and Reproduction

Growth Hormone Therapy

30% Off Cycle 1. Possible Preliminary Discussions With Contract Negotiations

Master of Physician Assistant Studies Course Descriptions for Year I

Anatomy of Male Reproductive System

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME

Polycystic Ovary Syndrome

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

TUE Applications for Testosterone Physician Worksheet

Report to Congress Efforts to Treat Infertility of Military Families

MALE AND FEMALE IMMUNOLOGIC INFERTILITY. By : Dr J.José WOLOMBY (Kinshasa,R.D.Congo) Tutor : Dr A. de AGOSTINI (Geneva,Switzerland)

Vasectomy Services Patient Information

Shira Miller, M.D. Los Angeles, CA The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library

Consultations & other investigations

Fast Track to IVF. Objectives

Effect of occupational exposures on male fertility: literature review, Ind Health Apr;41(2):55-62.

it right? activity (page 4) to highlight ethical issues associated with IVF

Hypogonadism and Testosterone Replacement in Men with HIV

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

GUIDELINES ON MALE HYPOGONADISM

male sexual dysfunction

LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH:

Reproductive System & Development: Practice Questions #1

Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART)

No-Scalpel Vasectomy

Transcription:

Indian J Med Res 124, September 2006, pp 299-304 Hormonal abnormalities in azoospermic men in Kano, Northern Nigeria M.A. Emokpae, P.O. Uadia +, A.Z. Mohammed* & A. Omale-Itodo** Departments of Chemical Pathology, *Pathology, & **Obstetrics & Gynaecology, Aminu Kano Teaching Hospital, Kano & + Department of Biochemistry, University of Benin, Benin city, Nigeria Received December 19, 2005 Background & objectives: We undertook this study to observe the pattern of hormonal abnormalities and testicular pathology in azoospermic male Africans in Kano, Northern Nigeria. Methods: Eighty consecutive azoospermic infertile males attending fertility clinic in Aminu Kano Teaching Hospital, Kano, were selected for the study. Their semen were analyzed three times at eight weeks interval, after which serum follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone and prolactin were assayed in serum samples, and histological examination of testicular biopsies done. Results: Of the 80 subjects studied, 32 (40%) had abnormal hormonal levels, 48 (60%) had normal hormonal values and 36 (45%) had testicular pathology. Interpretation & conclusion: Endocrinopathies are common in azoospermia. Their contribution to male factor infertility cannot be overemphasized. The main reason for the endocrinopathies is not known but environmental factors, endocrine disruptors and genetic polymorphism have been suggested to be contributory. Key words Azoospermia - follicle stimulating hormone - luteinizing hormone - prolactin - testosterone Infertility is an important medical and social problem in the world. In about 60 per cent of all couples experiencing infertility, male factor is responsible in about 40 per cent of the couples 1. It is now generally accepted that the treatment of male factor infertility is equally as important as the treatment of the female factor. Studies from Nigeria have shown that azoospermia was present in 6.55 per cent 2 of males attending a general infertility clinic and 35 per cent 3 in those attending male infertility 299

300 INDIAN J MED RES, SEPTEMBER 2006 clinic. The causes of azoospermia such as failure of spermatogenesis and obstruction of the ductal system particularly the vas deferens have been investigated 4. It was reported that obstruction of the vas deferens was not a major cause of azoospermia in Nigeria 4,5. Infection of the seminal fluid has been implicated as the major cause of azoospermia in infertile males in eastern Nigeria 6. Since infections are known to damage the vas deferens and seminiferous tubules, the study of circulating levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), and testosterone are required 7. Post bacterial infections and idiopathic testicular pathology are documented as common causes of azoopermia 6. The present study was undertaken to examine the circulating levels of FSH, LH, prolactin (PRL) and testosterone as contributory factors to azoospermia in azoospermic male Africans attending the fertility clinic a hospital in northern Nigeria. The role of testicular pathology in the study group was also evoluated. Material & Methods results of semen analysis and histological evaluation of testicular biopsy were extracted from medical records of individual patients. These subjects had no history of diabetes or hypertension and of previous surgical operation. Only 10 patients (12.5%) admitted to consumption of alcohol occasionally while 50 (62.5%) admitted smoking cigarettes. Their azoospermic condition was confirmed when a repeat semen analysis showed no sperm cells while the mean sperm density of control subjects was 46.8 cells/ml. Blood samples were obtained for estimation of testosterone, prolactin (PRL), follicle stimulating hormone (FSH) and luteinizing hormone (LH). Sera were obtained after centrifugation at 1000 g for 10 min. The serum samples were kept at -20 o C until they were analyzed. FSH, LH, PRL and testosterone levels were quantitated by ROCHE ELECSYS 1010 using electrochemiluminescene immunoassay technique. Student s t test was used to compare the mean values and level of significance was set as P<0.05. A total of 80 consecutive infertile azoospermic males attending the fertility clinic of Aminu Kano Teaching Hospital Kano, Nigeria during 2002 to 2004, were included in this study. The age of these men ranged from 25-46 yr with a mean of 38.4 ± 3.2 yr. Twenty normospermic males aged 28-48 yr with a mean age of 39.5 ± 2.6 yr were included as control subjects. Ethical clearance was obtained from the Aminu Kano Teaching Hospital Ethics Committee and the medical records of the subjects were retrieved from the medical records department. Information regarding the past medical history, social history, physical examination of the testes, Results Of the 80 males, 32 (40%) had abnormal hormonal levels (Table), ten had elevated FSH and LH, diminished testosterone and normal prolactin levels, 12 had diminished FSH, LH, and prolactin and normal testosterone while four had elevated prolactin levels and normal levels of FSH, LH and testosterone. Two had isolated elevation of FSH and three had isolated elevation of LH level. Forty eight (60%) of these azoospermic subjects had normal levels of prolactin, FSH, LH and testosterone. Only one who had no ejaculate despite repeated achievement of orgasm had diminished level of

EMOKPAE et al: HORMONAL ABNORMALITIES IN AZOOSPERMIC AFRICANS 301 FSH, while prolactin, LH and testosterone were normal. Statistically significant differences were observed (P<0.001) when compared with the control subjects. On testicular biopsies of these azoospermic males, 17 (21.3%) had partial or complete spermatogenic arrest, eight (10%) had testicular atrophy, seven (8.75%) had moderate to severe hypospermatogenesis while two (2.5%) had epididymal ducts devoid of spermatozoa. One person each had testicular dysgenesis, and germinal cell aplasia. Forty four (55%) had no significant testicular pathology. Of the 10 subjects with primary hypogonadism, eight had testicular atrophy, one each had germinal cell aplasia and testicular dysgenesis. Ten of the 12 subjects with secondary hypogonadism had spermatogenic arrest and two had epididymal ducts devoid of spermatozoa, while four subjects with hyperprolactinaemia had hypospermatogenesis. However, seven males with normal hormonal levels had spermatogenic arrest while three had hypospermatogenesis. Two subjects with increased and one with decreased FSH and three with increased LH had normal testicular morphology. Discussion Our findings showed that hormonal abnormalities, underlying testicular pathology were common in this group of infertile azoospermic males. Evaluation of the infertile men requires a complete medical history, physical examination and laboratory investigations with the aim to identify and treat correctable causes. The purpose should be to counsel patients and spare the spouse of invasive procedures and potential complications Table Hormonal levels of azoospermic infertile males and control subjects Group Mean age Prolactin (ref FSH ref (range LH (ref range Testosterone (yr) range 86-390 4.6-12.4 4.0-8.6 (ref range miu/ml) miu/ml) miu/ml) 2.8-8.0 ng/ml) Primary hypogonadism (n=10) 37.4 ± 2.8 293.97 ± 32.6 40.7 ± 4.90** 11.94 ± 1.02** 1.99 ± 0.43** Secondary hypogonadism 37.3 ± 3.2 203.1 ± 22.3 1.84 ± 0.28** 2.36 ± 0.2** 3.01 ± 1.02** (hypogonadotropic hypogonadism) (n=12) Hyperprolactinaemia (n=4) 43.8 ± 3.8 726.0 ± 54.8** 12.3 ± 1.84 6.23 ± 0.26 5.85 ± 0.50 Isolated increase in 36.5 ± 2.1 301.2 ± 73.0 22.6 ± 1.51** 5.52 ± 0.97 2.53 ± 0.32** FSH levels (n=2) Isolated increase in 41.0 ± 3.2 313.5 ± 29.4 7.11 ± 2.07 11.31 ± 0.92 7.67 ± 0.60 LH Levels (n=3) Azoospermia with normal 37.4 ± 5.2 212.3 ± 12.7 7.13 ± 042 6.64 ± 0.27 5.68 ± 0.30 hormones (n=48) Normospermic males 38.2 ± 2.4 216.67 ± 16.1 7.89 ± 0.60 6.42 ± 0.33 5.58 ± 0.30 (46.8 x 10 6 cell/ml) (n=20) No ejaculation (n=1) 30 386.7 1.43 5.05 4.09 **P<0.001

302 INDIAN J MED RES, SEPTEMBER 2006 associated with such procedures 8. Oligospermia and azoospermia are common causes of male infertility in sub Saharan Africa 9,10. Our results showed that 40 per cent azoospermic males had abnormal hormonal levels, the pattern of abnormalities however varied, ten had primary hypogonadism. This is an indication of testicular failure in which there is loss of negative feedback by testicular products. There is defect in the testes despite increased levels of FSH and LH, the testes cannot produce adequate quality sperm cells. Marked elevation of FSH in the azoospermic patients strongly suggest testicular failure and a poor prognosis. This result is partly consistent with previous studies elsewhere 11-13. Fifteen per cent of our subjects had secondary hypogonadism. Hypogonadotropic hypogonadism is a result of decreased gonadotropin stimulation of potentially normal testes 14,15. Hyperprolactinaemia observed in four subjects partly confirms the earlier reports 16,17 that it is common in infertile Nigerian men. These hormonal abnormalities can be corrected if the patients report to the hospital early. It is usually recommended that clinical evaluations of the male partner be done after a year of unprotected intercourse has passed without conception 9,18. The isolated increase in FSH level may indicate disturbance of seminiferous tubules function probably due to deficient secretion of inhibin and sex steroids. However, clinical experience suggests that in some men an elevated FSH level may represent a hormone of reduced biologic activity or an imbalance in the gonadal-pituitary feedback mechanism and not irreversible germinal epithelial damage 15. Similarly isolated elevation of LH level may suggest the presence of a crossreacting substance such as hcg 14. One patient, who had no ejaculate despite achieving orgasm, had diminished FSH level with the other parameters within normal limits. The medical history of this patient revealed that his testies were pulled during a football match a couple of years earlier. Histological examination of testicular biopsies revealed that the azoospermic condition was not due to primary testicular defects in half of the subjects. Spermatogenic arrest, testicular atrophy and hypospermatogenesis were the most common testicular abnormalities observed in this study. The main causes of these conditions are not known, but the rapid pace of increasing incidence of azoospermia and other conditions responsible for male factor infertility point to environmental factors. Chromosomal abnormalities have also been reported to be as one of the genetic factors contributing to male infertility 19. Endocrine disrupting chemicals and genetic polymorphisms have been hypothesized to influence male reproductive health 20-23. The effects of environmental factors such as pesticide and heavy metal contamination require further investigation. Clinicians also need to bear in mind the possibility of intrinsic abnormalities of the testes as factors responsible for male infertility. In such situations prompt identification and correction of treatable conditions is vital in restoring fertility. Counseling is essential in selected patients such as testicular dysgenesis, where fertility cannot be improved, and alternative approaches such as artificial donor insemination, surrogacy and adoption should be considered. Hormonal therapy should be administered where appropriate to correct endocrine abnormities. In conclusion, male infertility is becoming an increasingly prominent contributory factor in the evaluation of infertile couples. Practitioners particularly reproductive endocrinologists and

EMOKPAE et al: HORMONAL ABNORMALITIES IN AZOOSPERMIC AFRICANS 303 fertility specialists require to recognize the varied spectrum of abnormalities in the male subjects. A comprehensive detailed laboratory work - up incorporating hormonal assessment, semen analysis and in selected patients histological evaluation of testicular biopsy material will substantially facilitate appropriate patient management. Acknowledgment The authors thank Mallam Mansur of the health records department, the fertility and urology teams, staff of chemical pathology and urogenital laboratories of Aminu Kano Teaching Hospital for their assistance. References 1. Werner MA. Male infertility. http/www.werner md com./ male infertility. 2. Marinho AO. Aetiological factors in infertility-a review of 277 infertile Nigerian couples. West Afri J Med 1986; 5 : 69-74. 3. Nkposong EO, Lawani J, Osanyintuji SO, Awojobi AO. Semen analysis in Ibadan. Nig Med J 1982; 12 : 181-6. 4. Ojengbede AO, Omonria WE, Ladipo AO. Screening for obstruction of the vas deferens in Nigerian men with azoospermia using the x-glucosidase reaction in semen. Afri J Med Sci 1992; 21 : 79-81. 5. Emokpae MA, Emokpae LA. Calcium concentration in semen of azoospermic Nigerians. J Med Lab Sci 1997; 6 : 42-3. guide for the physician, 3 rd ed. Oxford: Boston Blackwell Scientific Publications; 1992 p. 1-10. 10. Ajabor LM, Ezimokhai M, Kadiri A. Male contribution to sub-fertility in Benin City, Nigeria. Trop J Obstet Gynaecol 1981; 2 : 53-6. 11. Subhan F, Tahir F, Ahmed R, Khan ZU. The study of azoospermic patients in relation to their hormonal profile (LH, FSH and testosterone). Rawal Med J 1995; 22 : 25-7. 12. Subhan F, Tahir F, Alam W, Sultan S, Dil AS, Shahab M. Seminal and hormonal profiles of fertile and subfertile Pakistani men - a study of infertility cases. Pak J Med Res 2000; 39 : 42-5. 13. Khan MS, Subhan F, Kazi BM, Tahir F, Dil AS, Ali I, et al. Semen parameters and hormonal profile of infertile patients. Hamdard Med 2004; XLVII : 48-51. 14. Winters SJ. Evaluation of testicular function. In: Kenneth LB, editor. Principle and practice of endocrinology and metabolism. Philadelphia: JB Lippoincott Company; 1990 p. 942-8. 15. Plymate SR, Paulsen CA. Male hypogonadism. In: Kenneth LB, editor. Principle and practice of endocrinology and metabolism. Philadelphia: JB Lippincott Company; 1990 p. 948-70. 16. Kuku SF. African endocrine infertility - a review. Afri J Med Sci 1995; 24 : 111-23. 17. Kuku SF, Akinyanju PA, Ojiefo JO. Serum levels of gonadotropins, prolactin and testosterone in oligo/ azoospermic Nigerian males. Int J Fertile 1988; 3 : 40-4. 6. Megafu U. Seminal fluid infection and oligospermia. Trop J Obstet Gyneacol 1991; 9 : 10-2. 7. Emokpae MA. A review of laboratory investigations of male infertility. Nig J Med 1999; 8 : 104-7. 8. Kolettis PNB. Evaluation of the sub fertile man. Am Fam Physician 2003; 67 : 2165-71. 9. Talbert LM. Overview of the diagnostic evaluation. In: Hammond MG, Talbert LM, editors. Infertility - A practical 18. Mann T. The biochemistry of semen and of the male reproductive tract. New York: John Wiley and Sons; 1964 p. 100-6. 19. Nagvenkar P, Desai K, Hinduja I, Zaveri K. Chromosomal studies in infertile men with oligozoospermia and nonobstructive azoospermia. Indian J Med Res 2005; 122 : 11-2. 20. Toppari J, Haavisto AM, Alanen M. Changes in male reproductive health and effects of endocrine disruptors in

304 INDIAN J MED RES, SEPTEMBER 2006 Scandinavian countries. Cad Saude Publica 2002; 18 : 413-20. 21. Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebeak NE. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann NY Acad Sci 2001; 948 : 90-9. 22. Osoba AO, Sub-fertility and infertility in Africa. Adadevoh BK, editors. The caxton Press (W Africa) ltd Ibadan; 1974 p. 81. 23. Weber RF, de baat C. Male fertility. Possibly affected by occupational exposure to mercury. Ned Tijdschr Tandheelkd 2000; 107 : 495-8. Reprint requests: Dr M.A. Emokpae, Department of Chemical Pathology, Aminu Kano Teaching Hospital P.M.B. 3452, Kano, Nigeria e-mail: biodunemokpae@yahoo.com